| Literature DB >> 30453564 |
Corina Danciu1, Istvan Zupko2, Andrea Bor3, Anja Schwiebs4, Heinfried Radeke5, Monica Hancianu6, Oana Cioanca7, Ersilia Alexa8, Camelia Oprean9, Florina Bojin10, Codruta Soica11, Virgil Paunescu12, Cristina Adriana Dehelean13.
Abstract
Chamomile, parsley, andEntities:
Keywords: A375 human melanoma cells; anti-inflammatory; antioxidant; celery; chamomile; dendritic cells; parsley
Mesh:
Substances:
Year: 2018 PMID: 30453564 PMCID: PMC6274727 DOI: 10.3390/ijms19113624
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
The major polyphenolic compounds of the investigated plant samples by RP-UHPL (µg/100 µg extract).
| Chlorogenic Acid | Caffeic Acid | Catechin | Apigenin Glucoside | Rutin | Cinaroside | Luteolin | Apigenin | Kaempferol | |
|---|---|---|---|---|---|---|---|---|---|
| MC extract | 8.180 | 1.296 | 5.179 | 34.103 | 6.013 | 2.659 | 5.113 | 1.388 | - |
| P extract | 4.572 | 2.213 | - | 22.371 | - | 0.776 | 4.078 | 14.562 | 2.662 |
| C extract | 6.609 | 1.980 | - | 18.015 | - | 6.146 | 1.539 | 16.967 | 8.480 |
“-” not detected.
Figure 1UHPLC chromatogram of the investigated extracts: MC—chamomile flower extract, C- celery seeds extract, P—parsley seeds extract; Api-7-glu—apigenin glucoside, Api—apigenin.
Spectrophotometric quantification of flavonoids and total phenols in investigated extracts.
| Sample | Total Flavones (µg /mL Extract) | Total Phenols (µg GAE/mL Extract) |
|---|---|---|
| MC extract | 342.4 | 458.1 |
| P extract | 172.2 | 292.7 |
| C extract | 229.3 | 345.2 |
Radical scavenger capacity of the investigated extracts.
| Extract/Standard | EC50 (µg/mL) | |
|---|---|---|
| DPPH Assay | ABTS Assay | |
| MC extract | 47.8 ± 1.4 | 21.4 ± 0.2 |
| C extract | 157.9 ± 2.1 | 163.7 ± 1.3 |
| P extract | 165.4 ± 0.2 | 164.1 ± 1.5 |
| Caffeic Acid | 3.6 ± 0.0 | 1.6 ± 0.0 |
Iron chelation potential of the selected extracts.
| Sample | 0.078125 mg/mL | 0.15625 mg/mL | 0.3125 mg/mL | 0.625 mg/mL | 1.25 mg/mL | 2.5 mg/mL | 5 mg/mL | 10 mg/mL | EC50 (mg/mL Solution Final Tube) |
|---|---|---|---|---|---|---|---|---|---|
| MC extract | 3.12 ± 0.05 | 4.77 ± 0.05 | 10.25 ± 0.12 | 13.28 ± 0.10 | 25.41 ± 0.07 | 50.59 ± 0.12 | 69.89 ± 0.13 | 73.91 ± 0.02 | 491.94 ± 1.61 |
| C extract | 2.25 ± 0.03 | 3.00 ± 0.04 | 7.73 ± 0.04 | 19.91 ± 0.03 | 51.44 ± 0.01 | 88.15 ± 0.03 | 91.65 ± 0.04 | 92.96 ± 0.01 | 242.21 ± 0.06 |
| P extract | 6.84 ± 0.09 | 10.75 ± 0.04 | 12.39 ± 0.07 | 16.61 ± 0.13 | 24.21 ± 0.06 | 74.10 ± 0.02 | 93.55 ± 0.01 | 96.91 ± 0.03 | 357.72 ± 0.19 |
| Caffeic Acid | 97.03 ± 0.09 | 97.09 ± 0.14 | 98.36 ± 0.21 | 98.61 ± 0.32 | 99.27 ± 0.22 | 100 ± 0.00 | 100 ± 0.00 | - | 2.47 ± 0.25 |
“-” not detected.
Lipoxygenase inhibition activity of selected extracts.
| Sample | 0.078125 mg/mL | 0.15625 mg/mL | 0.3125 mg/mL | 0.625 mg/mL | 1.25 mg/mL | 2.5 mg/mL | 5 mg/mL | 10 mg/mL | EC50 (mg/mL Solution Final Tube) |
|---|---|---|---|---|---|---|---|---|---|
| MC extract | 4.71 ± 0.03 | 7.13 ± 0.54 | 12.30 ± 0.30 | 23.85 ± 0.37 | 35.40 ± 0.48 | 43.03 ± 0.31 | 59.95 ± 0.28 | 73.38 ± 0.20 | 166.32 ± 2.03 |
| C extract | 7.88 ± 0.28 | 12.84 ± 0.17 | 21.30 ± 0.89 | 30.06 ± 0.78 | 44.66 ± 0.97 | 56.22 ± 0.89 | 77.01 ± 0.66 | 100 ± 0.00 | 86.15 ± 4.82 |
| P extract | 7.44 ± 0.48 | 10.44 ± 0.34 | 16.73 ± 0.64 | 28.08 ± 0.30 | 46.08 ± 0.91 | 71.84 ± 0.93 | 80.87 ± 0.72 | 100 ± 0.00 | 69.46 ± 1.70 |
| Caffeic Acid | 95.13 ± 0.79 | 96.15 ± 0.48 | 97.53 ± 0.21 | 98.22 ± 0.32 | 99.27 ± 0.17 | 99.43 ± 0.93 | 100 ± 0.00 | 100 ± 0.00 | 1.24 ± 0.05 |
Figure 2Cell growth inhibition (%) ± SEM against A375 human melanoma cells after 72 h of incubation with (a) MC extract; (b) C extract; or (c) P extract. Statistical significance was assessed by one-way ANOVA with Newman–Keuls post-test for comparison of multiple groups * and **** indicate p < 0.05 and p < 0.0001 respectively, compared to the control group.
Figure 3Effect of MC, C, and P extracts on cell cycle phases for A375 melanoma cell line. Statistical significance was assessed by one-way ANOVA with Newman–Keuls post-test for comparison of multiple groups *, ** and *** indicate p < 0.05, p < 0.01 and p < 0.001, respectively, compared to the control group.
Figure 4R epresentative histograms that describe the effect of (A) MC, (B) C, (C) P on cell cycle phases of A375 melanoma cell line with the following assignments: (a) Control, (b) 30 μg/mL, (c) 60 μg/mL.
Figure 5Caspase 3 activity of A375 human melanoma cells after 72 h of incubation with (a) MC extract; (b) C extract; (c) P extract. Statistical significance was assessed by one-way ANOVA with Newman–Keuls post-test for comparison of multiple groups ** and *** indicate p < 0.01 and p < 0.001, respectively, compared to the control group.
Apoptotic events for A375 human melanoma cell line after incubation with selected extracts.
| Viable Cells | Early Apoptotic Cells | Late Apoptotic Cells | Necrotic Cells | |
|---|---|---|---|---|
| Control | 95.40 ± 1.89 | 3.10 ± 1.62 | 0.67 ± 0.21 | 0.83 ± 0.05 |
| MC extract (60 μg/mL) | 95.76 ± 0.16 | 1.50 ± 0.08 | 0.64 ± 0.08 | 2.1 ± 0.16 |
| C extract (60 μg/mL) | 95.19 ± 0.95 | 2.38 ± 0.60 | 0.82 ± 0.37 | 1.70 ± 1.17 |
| P extract (60 μg/mL) | 89.00 ± 0.09 | 7.30 ± 0.65 | 2.36 ± 0.24 | 1.34 ± 1.25 |
Figure 6Immunocytochemical evaluation of A375 human melanoma cells after incubation with selected extracts at a concentration of 60 μM; (a) caspase 2 evaluation; (b) p53 evaluation (Magnification 10×; Scale 200 μm).
Figure 7(A) Activation of human dendritic cells measured by cell expansion after 24 h stimulation with vehicle, MC extract, C extract, or P extract (60 µg/mL) in the absence (naïve) or presence of LPS. Naïve cells were set to 100%. (B) Representative transmitted light microscopic pictures 24 h after extract stimulation (60 µg/mL) of naïve human dendritic cells (Magnification 20×; black arrows indicate endocytic enlargement). (* p ≤ 0.05; n = 4).
Figure 8(A) XTT assay for metabolic activity of LPS-activated human dendritic cells stimulated with vehicle, MC extract, C extract, or P extract (60 µg/mL) for 48 h. (B) Representative confocal microscopic pictures of LPS-activated human dendritic cells treated with vehicle, MC extract, C extract, or P extract (60 µg/mL) for 48 h (blue = DAPI (Nulcei), red = phalloidin (F-actin); Magnification 63X; White arrows indicates endocytic enlargement). (C) Quantification of cytokines in the supernatant of LPS-activated human dendritic cells stimulated with vehicle, MC extract, C extract, or P extract (60 µg/mL) for 24 h (* p ≤ 0.05, n = 4).